Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

Frontal fibrosing alopecia in Brazil mostly affects postmenopausal women, often linked with hypothyroidism and eyebrow hair loss.

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Hair levels of estradiol and progesterone are higher in premenopausal than postmenopausal women, but the difference isn't statistically significant, indicating the need for a better measurement method.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

Leydig cell tumors can cause high testosterone and symptoms like hair loss in postmenopausal women, but surgery can improve these symptoms.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Doctors should check for serious tumor causes of high androgen levels in postmenopausal women and more research is needed on this condition.

Frontal fibrosing alopecia mainly affects postmenopausal women and may be linked to thyroid hormones.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

A postmenopausal woman's excess male hormone symptoms were caused by a rare adrenal gland tissue in her ovary.

A woman's high testosterone levels and related symptoms improved after ovary removal surgery.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Iron levels are linked to insulin resistance in men and postmenopausal women, but not in premenopausal women.

An 84-year-old woman's hair loss was due to a rare condition called Leydig cell hyperplasia, which was treated with surgery.

Bilateral salpingo-oophorectomy resolved hyperandrogenism in a postmenopausal woman with rare ovarian tumors.

Leydig cell tumors can cause high testosterone and symptoms in postmenopausal women, and removing them improves symptoms.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

A 71-year-old woman developed male-like features due to high testosterone levels caused by a benign ovarian tumor, which was successfully removed by surgery.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

Cosmetic treatments can replenish key amino acids in damaged hair, improving its strength and appearance.

Women have unique stroke risks due to hormones, contraceptives, pregnancy, and menopause.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.